Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0NO5E
|
||||
Former ID |
DNC010469
|
||||
Drug Name |
Ethyl 5-benzoyl-4-phenylthiazol-2-ylcarbamate
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Discovery agent | Investigative | [530752] | ||
Structure |
Download2D MOL |
||||
Formula |
C19H16N2O3S
|
||||
Canonical SMILES |
CCOC(=O)NC1=NC(=C(S1)C(=O)C2=CC=CC=C2)C3=CC=CC=C3
|
||||
InChI |
1S/C19H16N2O3S/c1-2-24-19(23)21-18-20-15(13-9-5-3-6-10-13)17(25-18)16(22)14-11-7-4-8-12-14/h3-12H,2H2,1H3,(H,20,21,23)
|
||||
InChIKey |
VMTZCTQCFMWSEO-UHFFFAOYSA-N
|
||||
PubChem Compound ID | |||||
Target and Pathway | |||||
Target(s) | Adenosine A3 receptor | Target Info | Inhibitor | [530752] | |
Adenosine A1 receptor | Target Info | Inhibitor | [530752] | ||
Adenosine A2b receptor | Target Info | Inhibitor | [530752] | ||
Adenosine A2a receptor | Target Info | Inhibitor | [530752] | ||
KEGG Pathway | cGMP-PKG signaling pathway | ||||
cAMP signaling pathway | |||||
Sphingolipid signaling pathway | |||||
Neuroactive ligand-receptor interaction | |||||
Morphine addictionhsa04015:Rap1 signaling pathway | |||||
Calcium signaling pathway | |||||
Vascular smooth muscle contraction | |||||
Alcoholismhsa04015:Rap1 signaling pathway | |||||
Parkinson's disease | |||||
Alcoholism | |||||
Pathway Interaction Database | C-MYB transcription factor networkhif2pathway:HIF-2-alpha transcription factor network | ||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.